Merck & Co., Inc. (NYSE:MRK) - Page 3

Short Interest Spikes in a Couple Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

Most of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. Coming this week are 12 of the 30 Dow components. The Dow ...
Read Full Story »

How the 30 Dow Stocks Are Doing in 2019

As 2019 unfolds, one question is likely on most investors’ minds: Is the bull market that began in March 2009 dead, or can it find its footing on less stable ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Stocks had traded lower on Tuesday, but Wednesday's early indications were to recover about half of those prior losses. After so much volatility, investors should be rethinking and considering how ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Merck & Co. Inc. (NYSE: MRK) has announced that its blockbuster drug Keytruda received a series of approvals in Japan. The firm said that its anti-PD-1 therapy has simultaneously received ...
Read Full Story »

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

As 2019 gets into gear, there is a simple question that comes with a very difficult answer. Is the bull market that has raged since March of 2009 dead, or ...
Read Full Story »

Meet the 2019 Dogs of the Dow

Investors love their dividends. It was no secret that the bull market’s strength and reputation heading into the end of 2018 was tarnished. In fact, on the last trading day ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Health Care Catalysts Coming by the End of 2018

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

October turned out to be a very volatile month, with the stock markets seeing a correction and some sectors and many individual stocks slipping into bearish territory. Investors had plenty ...
Read Full Story »

Merck Takes Over as Dow’s Top-Performing Dow Stock

Last week saw the Dow recover a goodly portion of the previous week's loss. The move higher resulted in a change at the top as Merck & Co. Inc. (NYSE: ...
Read Full Story »